Randomised Evaluation of COVID-19 Therapy — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(7 sites)
Ghana
Kumasi Center for Collaborative Research in Tropical Medicine KNUST, Kumasi India
Indian Council of Medical Research, Division of Epidemiology and Communicable Diseases, New Delhi Indonesia
Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta Nepal
Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu South Africa
Wits Health Consortium, Johannesburg United Kingdom
Nuffield Department of Population Health, University of Oxford, Oxford Vietnam
Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City Age range
0 Years and older
Last updated January 2024